News

October 25, 2007 - Terumo Interventional Systems announced at TCT 2007 the launch of the TR Band, a radial artery compression device designed to safely and comfortably stop bleeding after transradial procedures, designed to allow the clinician to easily check for clotting and to promote greater patient comfort.

Home October 24, 2007
Home
News

October 24, 2007 – ev3 Inc. highlighted at TCT 2007 its merger with FoxHollow Technologies, Inc., which created an organization that possesses one of the largest U.S. distribution footprints in endovascular devices with combined technologies for the advancement of the treatment of peripheral and neurovascular disease.

Home October 23, 2007
Home
News

October 23, 2007 - Toshiba America Medical Systems Inc. today announced that the first U.S. installation of the Infinix ...

Home October 22, 2007
Home
News

October 23, 2007 - ENDEAVOR IV reached its primary endpoint of target vessel failure non-inferiority when compared to ...

Home October 22, 2007
Home
News

OCTOBER 23, 2007 – Abbott’s fully bioabsorbable drug eluting stent platform for the treatment of coronary artery disease ...

Home October 22, 2007
Home
News

October 23, 2007 - PLC Systems Inc. introduced at TCT 2007 the RenalGuard System, an investigational system and therapy ...

Home October 22, 2007
Home
News

October 23, 2007 - Hologic Inc.

Home October 22, 2007
Home
News

October 23, 2007 – Patients who received the CYPHER Sirolimus-eluting coronary stent had a lower risk of stent ...

Home October 22, 2007
Home
News

October 22, 2007 – A time-motion study conducted at Providence Heart Institute in Columbia, SC, spanning approximately ...

Home October 22, 2007
Home
News

October 22, 2007 – At TCT 2007, ProSolv CardioVascular, a FUJIFILM company, (ProSolv) demonstrated its advanced ...

Home October 22, 2007
Home
News

October 23, 2007 – After 12 months of the SPIRIT III trial, there were significantly fewer major adverse cardiac events (MACE) such as heart attacks, deaths from cardiac causes or repeat procedures (angioplasty or surgery) to clear the original vessel blockage after using a Xience V everolimus-eluting coronary stent than a Taxus paclitaxel-eluting stent, researchers reported at TCT 2007.

Home October 22, 2007
Home
News

October 22, 2007 – Stent thrombosis rates through one year were low for both the TAXUS Express2 Paclitaxel-Eluting ...

Home October 21, 2007
Home
News

October 22, 2007 – Philips highlighted the integration of Volcano’s IVUS into its new Xper system and TrueView’s ability ...

Home October 21, 2007
Home
News

October 22, 2007 - Implantation of the CYPHER Sirolimus-eluting Coronary Stent by Cordis Corp. used to treat completely ...

Home October 21, 2007
Home
News

October 22, 2007 - GE Healthcare highlighted the advantages of its digital flat panel Biplane imaging systems, the ...

Home October 21, 2007
Home
Subscribe Now